Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

111.60p
   
  • Change Today:
      1.20p
  • 52 Week High: 112.00
  • 52 Week Low: 82.00
  • Currency: UK Pounds
  • Shares Issued: 538.23m
  • Volume: 618,710
  • Market Cap: £600.66m
  • RiskGrade: 119
  • Beta: 0.00

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 111.60p per share. In the last year Alliance Pharma's share price has ranged from 82.00p to 112.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 1.5% 1.7%
Div Cover 3.2 3.3
Op Mrgn 12.6% 22.1%
ROCE 26.1%  
Latest F'cast
P/E 21.2 19.7
PEG 9.0 2.6
Pr/Revenue 4.6 3.5
Pr/Book 2.1  
Latest F'cast
Revenue -4.3% 30.3%
PBT -58.1% 186.6%
EPS 2.4% 7.5%
DPS 200.4% 5.6%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.21p 16.8 8.4 +2% 1.61p 1.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 169.10 37.30 5.60p 19.7 2.6 +8% 1.70p 1.7%
31-Dec-22 185.90 43.10 6.30p 17.5 1.4 +12% 1.70p 1.7%
31-Dec-23 201.10 48.30 6.70p 16.5 2.6 +6% 1.80p 1.7%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Notification of Major Holdings 18-Jan-2022 07:30 RNS
Full Year Trading Update 18-Jan-2022 07:00 RNS
Total Voting Rights 04-Jan-2022 18:04 RNS

Alliance Pharma ShareCast News

Alliance Pharma set to top underlying profit exp... 18-Jan-2022 ShareCast
Alliance Pharma trades strongly in first half 21-Sep-2021 ShareCast
Alliance Pharma trades strongly through first half 20-Jul-2021 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 111.60p
Change Today 1.20p
% Change 1.09 %
52 Week High 112.00
52 Week Low 82.00
Volume 618,710
Shares Issued 538.23m
Market Cap £600.66m
Beta 0.00
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.85% below the market average89.85% below the market average89.85% below the market average89.85% below the market average89.85% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Price Trend
72.26% above the market average72.26% above the market average72.26% above the market average72.26% above the market average72.26% above the market average
67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average
Income
56.94% below the market average56.94% below the market average56.94% below the market average56.94% below the market average56.94% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
17.66% below the market average17.66% below the market average17.66% below the market average17.66% below the market average17.66% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 19-Jan-2022

Time Volume / Share Price
13:04 250 @ 111.60p
13:01 367 @ 111.40p
12:58 2 @ 111.22p
12:52 200 @ 111.19p
12:48 4,500 @ 111.38p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page